IOM Committee Questions Adequacy Of Compliance Tools In 510(k) Program

Questions about the adequacy of FDA's compliance and surveillance tools for 510(k) products were among those raised by an Institute of Medicine task force during its second public meeting to evaluate the pre-market clearance program